SE8703539L - Artificiell gen och proteinprodukt - Google Patents

Artificiell gen och proteinprodukt

Info

Publication number
SE8703539L
SE8703539L SE8703539A SE8703539A SE8703539L SE 8703539 L SE8703539 L SE 8703539L SE 8703539 A SE8703539 A SE 8703539A SE 8703539 A SE8703539 A SE 8703539A SE 8703539 L SE8703539 L SE 8703539L
Authority
SE
Sweden
Prior art keywords
serum albumin
human serum
disclosed
authentic human
coding
Prior art date
Application number
SE8703539A
Other languages
Unknown language ( )
English (en)
Other versions
SE8703539D0 (sv
SE459586B (sv
Inventor
A Simoncsits G B Aaberg
M Kalman
I Cserpan
G Bajszar
Original Assignee
Mta Szegedi Biolog Koezponti
Skandigen Ab
Vepex Contractor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20369553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8703539(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of SE8703539D0 publication Critical patent/SE8703539D0/sv
Priority to SE8703539A priority Critical patent/SE459586B/sv
Application filed by Mta Szegedi Biolog Koezponti, Skandigen Ab, Vepex Contractor filed Critical Mta Szegedi Biolog Koezponti
Priority to EP88850299A priority patent/EP0308381B1/en
Priority to DD88319742A priority patent/DD282473A5/de
Priority to CA000577208A priority patent/CA1340650C/en
Priority to PCT/SE1988/000470 priority patent/WO1989002467A1/en
Priority to AU24204/88A priority patent/AU619495B2/en
Priority to AT88850299T priority patent/ATE135740T1/de
Priority to JP63507383A priority patent/JP2865683B2/ja
Priority to DE3855122T priority patent/DE3855122T2/de
Priority to PL27466988A priority patent/PL274669A1/xx
Priority to IL87748A priority patent/IL87748A/xx
Publication of SE8703539L publication Critical patent/SE8703539L/sv
Publication of SE459586B publication Critical patent/SE459586B/sv
Priority to FI901219A priority patent/FI901219A0/fi
Priority to NO90901177A priority patent/NO901177L/no
Priority to DK064990A priority patent/DK163937C/da
Priority to US07/884,274 priority patent/US5879907A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8703539A 1987-09-14 1987-09-14 Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning SE459586B (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE8703539A SE459586B (sv) 1987-09-14 1987-09-14 Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning
EP88850299A EP0308381B1 (en) 1987-09-14 1988-09-13 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
DD88319742A DD282473A5 (de) 1987-09-14 1988-09-13 Kuenstliche gencodierung fuer authentisches menschliches serum alkunin, dessen verwendung und verfahren zur herstellung desselben
CA000577208A CA1340650C (en) 1987-09-14 1988-09-13 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
PCT/SE1988/000470 WO1989002467A1 (en) 1987-09-14 1988-09-13 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
AU24204/88A AU619495B2 (en) 1987-09-14 1988-09-13 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
AT88850299T ATE135740T1 (de) 1987-09-14 1988-09-13 Artifizielles gen, das für humane serumalbumine kodiert, seine verwendung und verfahren zu seiner herstellung
JP63507383A JP2865683B2 (ja) 1987-09-14 1988-09-13 真正のヒト血清アルブミンをコードする人工遺伝子、その使用およびその製造法
DE3855122T DE3855122T2 (de) 1987-09-14 1988-09-13 Artifizielles Gen, das für humane Serumalbumine kodiert, seine Verwendung und Verfahren zu seiner Herstellung
PL27466988A PL274669A1 (en) 1987-09-14 1988-09-14 Method of obtaining a gene able to code authentical human serum albumin
IL87748A IL87748A (en) 1987-09-14 1988-09-14 Structural gene coding for human serum albumin, its production and its use
FI901219A FI901219A0 (fi) 1987-09-14 1990-03-12 Artificiell gen, som kodar foer autentiskt maenskligt serumalbumin, dess anvaendning och foerfarande foer framstaellning daerav.
NO90901177A NO901177L (no) 1987-09-14 1990-03-13 Syntetisk gen som koder for autentisk humant serumalbumin, anvendelse derav samt fremgangsmaate for fremstilling av genet.
DK064990A DK163937C (da) 1987-09-14 1990-03-13 Strukturelt gen, som koder for autentisk humant serumalbumin til ekspression i en ikke-human vaert, fremgangsmaade til fremstilling deraf, rekombinant-dna-molekyle indeholdende genet, vaertsorganisme transformeret dermed og fremgangsmaade til fremstilling af autentisk humant serumalbumin
US07/884,274 US5879907A (en) 1987-09-14 1992-05-13 Artificial gene coding for authentic human serum albumin, use thereof and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8703539A SE459586B (sv) 1987-09-14 1987-09-14 Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning

Publications (3)

Publication Number Publication Date
SE8703539D0 SE8703539D0 (sv) 1987-09-14
SE8703539L true SE8703539L (sv) 1989-03-15
SE459586B SE459586B (sv) 1989-07-17

Family

ID=20369553

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703539A SE459586B (sv) 1987-09-14 1987-09-14 Strukturgen som kodar foer autentiskt humant serum albumin och foerfarande foer dess framstaellning

Country Status (12)

Country Link
EP (1) EP0308381B1 (sv)
JP (1) JP2865683B2 (sv)
AT (1) ATE135740T1 (sv)
CA (1) CA1340650C (sv)
DD (1) DD282473A5 (sv)
DE (1) DE3855122T2 (sv)
DK (1) DK163937C (sv)
FI (1) FI901219A0 (sv)
IL (1) IL87748A (sv)
PL (1) PL274669A1 (sv)
SE (1) SE459586B (sv)
WO (1) WO1989002467A1 (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2791418B2 (ja) * 1987-12-02 1998-08-27 株式会社ミドリ十字 異種蛋白質の製造方法、組換えｄｎａ、形質転換体
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
US5759802A (en) * 1988-10-26 1998-06-02 Tonen Corporation Production of human serum alubumin A
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
ATE92107T1 (de) * 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
GB8909916D0 (en) * 1989-04-29 1989-06-14 Delta Biotechnology Ltd Polypeptides
JPH0669365B2 (ja) * 1989-05-22 1994-09-07 株式会社ミドリ十字 アルブミン遺伝子を含むプラスミド、形質転換体、形質転換体の製造方法、アルブミンの製造方法
CA2017176A1 (en) * 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
NL8901932A (nl) * 1989-07-26 1991-02-18 Mogen Int Produktie van heterologe eiwitten in planten of plantecellen.
GB8923521D0 (en) * 1989-10-18 1989-12-06 Delta Biotechnology Ltd Yeast promoter
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
JPH07308199A (ja) * 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
US5514551A (en) * 1994-10-14 1996-05-07 Gen-Probe Incorporated Compositions for the detection of Chlamydia trachomatis
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
ES2500918T3 (es) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Proteínas de fusión de albúmina e interferón beta
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0079739A3 (en) * 1981-11-12 1984-08-08 The Upjohn Company Albumin-based nucleotides, their replication and use, and plasmids for use therein
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
EP0192738A4 (en) * 1984-08-29 1987-06-25 Chiron Corp EXPRESSION OF HUMAN CONJUNCTIVE TISSUE ACTIVATOR AND RELATED PEPTIDES.
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
HU194308B (en) * 1984-11-23 1988-01-28 Mta Szbk Genetikai Intezete Process for preparing oligo- and polydeoxyribonucleotides
KR870000428A (ko) * 1985-06-17 1987-02-18 . 인체혈청 알부민의 제조방법
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins

Also Published As

Publication number Publication date
PL274669A1 (en) 1989-08-21
DK163937C (da) 1992-09-14
IL87748A0 (en) 1989-02-28
SE8703539D0 (sv) 1987-09-14
DK64990D0 (da) 1990-03-13
WO1989002467A1 (en) 1989-03-23
JP2865683B2 (ja) 1999-03-08
DE3855122T2 (de) 1996-10-17
EP0308381A1 (en) 1989-03-22
SE459586B (sv) 1989-07-17
CA1340650C (en) 1999-07-13
ATE135740T1 (de) 1996-04-15
DE3855122D1 (de) 1996-04-25
DK64990A (da) 1990-05-14
DK163937B (da) 1992-04-21
IL87748A (en) 1993-06-10
EP0308381B1 (en) 1996-03-20
JPH03501323A (ja) 1991-03-28
FI901219A0 (fi) 1990-03-12
DD282473A5 (de) 1990-09-12

Similar Documents

Publication Publication Date Title
SE8703539L (sv) Artificiell gen och proteinprodukt
NZ218332A (en) Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
DE3669175D1 (de) Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung.
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
FI90667C (sv) Förfarande för framställning av nytt interferonprotein av human typ I
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
SE8105516L (sv) Syntetisk dna och forfarande for framstellning derav
SE8605621D0 (sv) Heteromultimeric proteins and their manufacture
ATE100495T1 (de) Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ATE91717T1 (de) Verfahren zur herstellung von proteinen in loeslicher form.
NO874704L (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
HUP9800520A2 (hu) Génexpresszió emlős sejtekben
EP0261534A3 (en) Improved gene expression in yeast
DE69533840D1 (de) Verbesserter expressionsvektor für die herstellung rekombinanter proteine
ES8400876A1 (es) "un metodo para preparar una vacuna para estimular la produccion de anticuerpos contra el virus de la glosopeda".
ES8306795A1 (es) Un metodo de preparar una molecula de acido desoxirribonu- cleico (adn)
FI934079A (sv) Förfarande för framställning av fusionprotein

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8703539-0

Format of ref document f/p: F

NAV Patent application has lapsed

Ref document number: 8703539-0

Format of ref document f/p: F